ClinicalTrials.gg

Program

Levornidazole Disodium Phosphate for Injection

Its studies are mostly in Renal Insufficiency · Intraabdominal Infections, led by Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical.

Furthest: phase 4, since Feb 10, 20254 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical40 open or runningphase 4since Feb 10, 2025Feb 10, 2025none ahead

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Feb 10, 2025First study: phase 4 study in Intraabdominal InfectionsFirst studyNCT06828874 · 696 enrolled · China
  2. Jun 13, 2025Phase 1 study in Renal InsufficiencyNCT07033182 · 24 enrolled · China
  3. Oct 22, 20262 phase 1 studiesNCT07906197, NCT07906171

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

All 4 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07906197Mass Balance Study · China1CompletedDec 5, 20246
NCT07906171Hepatic Impairment · China1CompletedSep 21, 202425
NCT07033182Renal Insufficiency · China1CompletedApr 7, 202424
NCT06828874Intraabdominal Infections · China4CompletedSep 23, 2024696

How it is read

Names in the registry

  • “Levornidazole Disodium Phosphate for Injection”, 6 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.